bazedoxifene
Showing 1 - 25 of 50
Breast Cancer Stage IV, Unresectable Locally Advanced Invasive Breast Cancer, Metastatic Invasive Breast Cancer Trial in Boston
Completed
- Breast Cancer Stage IV
- +2 more
- Palbociclib
- Bazedoxifene
-
Boston, Massachusetts
- +1 more
Oct 21, 2022
Pancreas Cancer Trial in Fribourg (Bazedoxifene 20 mg)
Recruiting
- Pancreas Cancer
- Bazedoxifene 20 mg
-
Fribourg, SwitzerlandHFR Fribourg - cantonal hospital
Feb 9, 2022
Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting Trial in San Francisco (Bazedoxifene Acetate)
Recruiting
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Bazedoxifene Acetate
-
San Francisco, CaliforniaWeill Institute for Neurosciences, University of California, San
Mar 21, 2022
Increased Risk for Development of Breast Cancer Trial in Kansas City (bazedoxifene plus conjugated estrogens)
Recruiting
- Increased Risk for Development of Breast Cancer
- bazedoxifene plus conjugated estrogens
-
Kansas City, KansasUniversity of Kansas Medical Center
Jan 9, 2022
Endometriosis Trial in New Haven (simvastatin 10mg, Bazedoxifene 20/Estrogens,Con 0.45Mg Tb, Placebo)
Recruiting
- Endometriosis
- simvastatin 10mg
- +2 more
-
New Haven, ConnecticutThe John B. Pierce Laboratory
Dec 8, 2022
Risk Reduction, Breast Cancer Trial in United States (Bazedoxifene and Conjugated Estrogens)
Recruiting
- Risk Reduction
- Breast Cancer
- Bazedoxifene and Conjugated Estrogens
-
Duarte, California
- +4 more
Feb 14, 2022
Menopause, Prediabetes, Obesity Trial in New Orleans (Placebo, conjugated estrogens/bazedoxifene (CE/BZA))
Not yet recruiting
- Menopause
- +2 more
- Placebo
- conjugated estrogens/bazedoxifene (CE/BZA)
-
New Orleans, LouisianaSoutheast Louisiana Veterans Health Care System, New Orleans, LA
Jan 12, 2023
Hand Osteoarthritis Trial in Faringdon, London, Oxford (Estrogen-bazedoxifene, Placebo oral tablet)
Completed
- Hand Osteoarthritis
- Estrogen-bazedoxifene
- Placebo oral tablet
-
Faringdon, Oxfordshire, United Kingdom
- +2 more
Apr 13, 2022
Arthritis, Rheumatoid Trial in Seoul (Bazedoxifene, Calcium/Vit D)
Completed
- Arthritis, Rheumatoid
- Bazedoxifene
- Calcium/Vit D
-
Seoul, Korea, Republic ofHanyang University
Aug 10, 2020
Focus of Study is Healthy Women at Risk for Breast Cancer Trial in Kansas City (DUAVEE 0.45Mg-20Mg Tablet)
Terminated
- Focus of Study is Healthy Women at Risk for Breast Cancer
- DUAVEE 0.45Mg-20Mg Tablet
-
Kansas City, KansasUniversity of Kansas Medical Center
Oct 22, 2021
(PASS) in the European Union (EU)
Completed
- Osteoporosis, Postmenopausal
- Bazedoxifene
- +2 more
- (no location specified)
Apr 27, 2020
Menopause, Depression, Anxiety, Sleep Trial (Duavive 0.45Mg-20Mg Tablet)
Not yet recruiting
- Menopause
- +2 more
- Duavive 0.45Mg-20Mg Tablet
- (no location specified)
Oct 21, 2020
Schizophrenia, Schizophreniform Disorders, Schizo Affective Disorder Trial in Melbourne (Bazedoxifene Acetate, Placebo)
Recruiting
- Schizophrenia
- +2 more
- Bazedoxifene Acetate
- Placebo
-
Melbourne, Victoria, AustraliaMonash Alfred Psychiatry Research Centre
Jan 6, 2020
Ductal Breast Carcinoma In Situ, Postmenopausal Trial in United States (drug, other, procedure)
Recruiting
- Ductal Breast Carcinoma In Situ
- Postmenopausal
- Conjugated Estrogens/Bazedoxifene
- +5 more
-
Aurora, Colorado
- +9 more
May 27, 2021
Menopause Trial in Baton Rouge (TSEC (Tissue-selective estrogen complexes), Placebo)
Completed
- Menopause
- TSEC (Tissue-selective estrogen complexes)
- Placebo
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Jan 19, 2022
Post-fracture Medication and Mortality
Completed
- Osteoporosis
- +4 more
- Anti-osteoporosis medications
-
Tainan, TaiwanDepartment of Family Medicine, National Cheng Kung Univ Hosp
May 9, 2022
Obesity, Glucose Homeostasis, Postmenopausal Symptoms Trial in New Orleans (Bazedoxifene/Conjugated Estrogens (BZA/CE), Placebo
Completed
- Obesity
- +2 more
- Bazedoxifene/Conjugated Estrogens (BZA/CE)
- Placebo Oral Tablet
-
New Orleans, LouisianaTulane University Clinical Translational Unit
Jul 4, 2018
Menopause, Multiple Sclerosis Trial in San Francisco (Tissue Selective Estrogen Complex, Placebo)
Completed
- Menopause
- Multiple Sclerosis
- Tissue Selective Estrogen Complex
- Placebo
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 29, 2020
Healthy Trial in Busan (AK-R215, Bazedoxifene 20 mg, Cholecalciferol 800IU)
Unknown status
- Healthy
- AK-R215
- +2 more
-
Busan, Korea, Republic ofDong-A University Hospital
Oct 22, 2017
Osteoporosis, Postmenopausal Trial in Gyeonggi-do (HUG186-B and HUG186-D, HUG186)
Unknown status
- Osteoporosis, Postmenopausal
- HUG186-B and HUG186-D
- HUG186
-
Gyeonggi-do, Seongnam-si, Korea, Republic ofHuons
Mar 16, 2018
Comparison Between Raloxifene and Bazedoxifene
Unknown status
- Selective Estrogen Receptor Modulator
-
Yokkaichi, Mie, JapanTomidahama Hospital
Oct 18, 2016
Healthy Trial (Treatment B, Treatment C, Treatment BC)
Unknown status
- Healthy
- Treatment B
- +2 more
- (no location specified)
Dec 23, 2016
Assess Safety And Efficacy Profile Of Viviant In Usual Practice
Completed
- Osteoporosis
-
Haeundae-gu, Busan, Korea, Republic of
- +59 more
May 31, 2018